A Phase I Dose-finding Trial of Hyperthermic Intraperitoneal Paclitaxel Combined With Cisplatin

NCT05620654 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Hyperthermic Intraperitoneal Chemotherapy
Paclitaxel

Interventions

DRUG: Hyperthermic Intraperitoneal Paclitaxel Combined With Cisplatin

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University